Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

B-cell Lymphoma · Burkitt Lymphoma · Diffuse Large B Cell Lymphoma · Follicular Lymphoma · Mantle Cell Lymphoma · Marginal Zone Lymphoma · Transformed Non-Hodgkin Lymphoma · Richter Syndrome · Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

New York Medical Center, Valhalla, New York, United States
Contact: Study coordinator (Kayleigh Klose, MD) · kayleigh.klose@wmchealth.org

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Large B-cell Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Study of SGR-1505 in Mature B-Cell Neoplasms

Mature B-Cell Neoplasm · Non Hodgkin Lymphoma · DLBCL

Abroad (travel likely)RecruitingPHASE1

Gilbert, United States · Newark, United States

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

B-Cell Lymphoma · B Acute Lymphoblastic Leukemia · Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

Diffuse Large B-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China